TCR-T Cell Therapy targeting KRAS G12V/G12D

KRAS G12V/G12D-targeted T cell receptor therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCR-T Cell Therapy targeting KRAS G12V/G12D, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors [EARLY_Phase 1]